Eledon Pharmaceuticals, Inc.
Pharmaceutical company · Irvine, California, United States · Nasdaq: ELDN
Eledon Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Irvine, California, United States. Its shares trade on Nasdaq under the ticker ELDN. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2024.
Eledon Pharmaceuticals at a glance
What does Eledon Pharmaceuticals do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $50 million sold (2024).
Frequently asked questions about Eledon Pharmaceuticals
Where is Eledon Pharmaceuticals headquartered?
Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California, United States.
What does Eledon Pharmaceuticals do?
Eledon Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Eledon Pharmaceuticals a public company?
Yes. Eledon Pharmaceuticals, Inc. trades on Nasdaq under the ticker ELDN.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.